Sameer Gafoor (@sameergafoor) 's Twitter Profile
Sameer Gafoor

@sameergafoor

Structural heart specialist by day, sometimes by night. Interested in devices, health, & tech. Tweets my opinion not med advice.

ID: 91708490

calendar_today22-11-2009 02:55:15

1,1K Tweet

2,2K Takipçi

4,4K Takip Edilen

Cinch Medical (@cinchmedtech) 's Twitter Profile Photo

Great review in Circulation! We completely agree, #tricuspid #annuloplasty has the potential to be the natural, first-line treatment of #treatTR!

Great review in <a href="/CircAHA/">Circulation</a>! We completely agree, #tricuspid #annuloplasty has the potential to be the natural, first-line treatment of #treatTR!
Sameer Gafoor (@sameergafoor) 's Twitter Profile Photo

SCAI ALERT: want to learn about #structuralheart #fellowship Providence Swedish team in Seattle ? Great volume, hands-on teaching, next gen trials, program building, career mentorship. I'll be #SCAI2024 this week - reach out and learn more! #JSCAI #SoMe #interventionalcardiology

<a href="/SCAI/">SCAI</a>  ALERT: want to learn about  #structuralheart #fellowship <a href="/ProvSwedish/">Providence Swedish</a> team in Seattle ? Great volume, hands-on teaching, next gen trials, program building, career mentorship. I'll be #SCAI2024 this week  - reach out and learn more! #JSCAI #SoMe #interventionalcardiology
CSI Congress (@csicongress) 's Twitter Profile Photo

The deadline is approaching! Don't miss your chance on winning a €10.000 cash prize, and clinical research services worth another €10.000, and become a part of the CSI Innovation session at #CSIFrankfurt2024. Submit a presentation on your start-up company here:

The deadline is approaching! Don't miss your chance on winning a €10.000 cash prize, and clinical research services worth another €10.000, and become a part of the CSI Innovation session at #CSIFrankfurt2024.

Submit a presentation on your start-up company here:
Sameer Gafoor (@sameergafoor) 's Twitter Profile Photo

Are we only halfway there getting patients to treatment? Data show over 50% of eligible patients don’t receive AVR. I’m highlighting how we can confront this critical health issue through multidisciplinary partnership with Edwards Lifesciences bit.ly/3Dtbdpl

Are we only halfway there getting patients to treatment? Data show over 50% of eligible patients don’t receive AVR. I’m highlighting how we can confront this critical health issue through multidisciplinary partnership with <a href="/EdwardsLifesci/">Edwards Lifesciences</a> bit.ly/3Dtbdpl
Sameer Gafoor (@sameergafoor) 's Twitter Profile Photo

Aortic stenosis threatens heart health, and increased severity means faster progression. I’m collaborating with Edwards Lifesciences to emphasize how referring severe patients early keeps sudden progression from going unchecked. Learn more: bit.ly/3VNTAqk

Aortic stenosis threatens heart health, and increased severity means faster progression. I’m collaborating with <a href="/EdwardsLifesci/">Edwards Lifesciences</a> to emphasize how referring severe patients early keeps sudden progression from going unchecked. Learn more: bit.ly/3VNTAqk